Ticker Scorecard - AVNS Basics Company: Avanos Medical, Inc. IPO Date: October 20, 2014 Sector: Healthcare Industry: Biotech Market Cap: $679.47M Activated in VL: True Average Daily Range Avg Daily Range: $0.51 | 1.59% Avg Daily Range (30 D): $0.18 | 1.15% Avg Daily Range (90 D): $0.24 | 1.44% Institutional Daily Volume Avg Daily Volume: .25M Avg Daily Volume (30 D): .35M Avg Daily Volume (90 D): .35M Trade Size Avg Trade Size (Sh.): 63 Avg Trade Size (Sh.) (30 D): 52 Avg Trade Size (Sh.) (90 D): 56 Institutional Trades Total Inst.Trades: 2,497 Avg Inst. Trade: $1.57M Avg Inst. Trade (30 D): $1.2M Avg Inst. Trade (90 D): $1.28M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.57M Avg Closing Trade (30 D): $1.23M Avg Closing Trade (90 D): $1.28M Avg Closing Volume: 50.6K     News Dec 30, 2024 @ 12:58 PM United States Syringes, Needles and Urinary Cathet... Source: Researchandmarkets.Com Oct 6, 2024 @ 11:30 PM Bio Pharma Buffer Market to Reach $2.4 Billion, Gl... Source: Allied Market Research Aug 29, 2024 @ 12:17 PM Pain Management Devices Market to Witness 21.5 % C... Source: Globe Newswire Aug 5, 2024 @ 11:52 AM Is Phibro (PAHC) Stock Worth Retaining in Your Por... Source: N/A Jun 6, 2024 @ 3:31 PM Globus Medical (GMED) Up 7.4% Since Last Earnings ... Source: Zacks Equity Research Financials   TTM Q4 2024 FY 2024 Basic EPS $-8.53 $-8.64 $-8.53 Diluted EPS $-8.53 $-8.64 $-8.53 Revenue $ 687.8M $ 179.6M $ 687.8M Gross Profit $ 381.3M $ 98M $ 381.3M Net Income / Loss $ -392.1M $ -397.3M $ -392.1M Operating Income / Loss $ -396.2M $ -418.5M $ -396.2M Cost of Revenue $ 306.5M $ 81.6M $ 306.5M Net Cash Flow $ 20M $ 18.7M $ 20M PE Ratio     Splits May 15, 2006:   100:1